Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)

  Print   

Tuesday 27 October, 2020

Benchmark Hlgs PLC

Notice of Results

RNS Number : 2136D
Benchmark Holdings PLC
27 October 2020
 

27 October 2020

 

Benchmark Holdings plc

 

("Benchmark" or the "Company")

 

Notice of Full Year Results

 

 

Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its full year results, for the period ended 30 September 2020, on Friday 27 November 2020. 

 

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts on that day at 8:30am UK time. To register your interest, please contact  [email protected] .

 

 

  Enquiries

For further information, please contact:


Benchmark Holdings plc

Tel:  020 3696 0630

Trond Williksen, CEO


Septima Maguire, CFO


Ivonne Cantu, Investor Relations






Numis (Broker and NOMAD)

Tel:  020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith




MHP Communications

Tel:  020 3128 8990

Katie Hunt, Reg Hoare, Alistair de Kare-Silver, Charlie Protheroe

[email protected]






About Benchmark

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORFQLFLBBLEFBB

a d v e r t i s e m e n t